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Purpose	
Three New York State practice-based research networks provided quality improvement strategies to
improve screening rates for breast, cervical, and colorectal (BCC) cancers in safety-net primary care,
over 7 years. In the final year (Y7), the United States experienced the COVID-19 pandemic. The
impact of the COVID-19 pandemic on BCC cancer screening rates was assessed qualitatively.
Methods 	A total of 12 primary care practices participated in Y7 of the quality improvement project. BCC cancer
screening rates at year beginning and end were assessed. Practice staff were asked about how
COVID-19 impacted screening. Average pre/postintervention screening rates and qualitative thematic
analysis regarding how COVID-19 impacted cancer screening were ascertained.
Results 	In Y7, there was an increase in breast cancer and a decrease in colorectal and cervical cancer screening
rates compared to the previous project year. Many practices were able to continue pre-COVID-19
cancer screening processes. Overall, practices reported loss of staff, changes in data entry, and a shift
from preventive screening to care of sick patients. Telehealth was vital for practices to continue serving
patients but had a less positive impact on patients with financial/technological disadvantages. BCC
cancer screenings were impacted at various levels.
Conclusions	The COVID-19 pandemic negatively impacted primary care practice cancer screening; however,
some practices were able to mitigate effects by shifting focus to processes supporting screening
outside of in-person office visits. (J Patient Cent Res Rev. 2021;8:347-353.)
Keywords	cancer screening; primary care; COVID-19; breast cancer; colorectal cancer; cervical cancer; telehealth
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Department of Health to target primary care practices
serving disadvantaged populations — known as safetynet practices — to engage them in improving screening
rates within their patient panels.
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Responding to this call, three practice-based research
networks administered across central and western New
York State partnered to provide quality improvement
(QI) strategies on colorectal, breast, and cervical cancer
screening through practice facilitation2-4 and academic
detailing5-7 to increase screening rates in safety-net
primary care practices over 7 years (2014–2020), ending
in June 2020. Characteristics of the populations served
and practice types are reported elsewhere, but briefly,
our safety-net clinics represented a mix of practices that

n the United States, screening rates for colorectal,
breast, and cervical cancer often fall below national
targets despite the current evidence of preventive
screening effectiveness.1 Compounding the problem,
screening rates in disadvantaged populations are generally
worse than for more well-off segments of society. This is
true in New York State, prompting the New York State
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included Federally Qualified Health Centers and academic
practices that saw patients who were underserved, either
through uninsurance, poor insurance, or lack of access
due to other reasons such as geographic or community
features. Aggregate increases in screening rates were
observed across participating practices for colorectal
and breast cancer, with more uneven results for cervical
cancer. Details of the overall project and outcomes are
available elsewhere.1,8-15
In the seventh and final year of this project (July 2019–
June 2020), the United States was beset by the COVID-19
global pandemic. The delivery of health care was
dramatically changed during this time. Preventive care
services were curtailed, patients feared going to a health
care facility, and social distancing required practices to
completely change their practice workflows. Regions
of New York State covered by our QI project spent the
final months of participation (March–June) socially
distancing and in mandated business closures, with travel
and mobility restrictions in place throughout the state.16,17
These measures had dramatic impacts on primary care
practice operations in the last 4 months of project year
7 (Y7), a time frame in previous years during which
practices were well into their interventions and routines
and winding down project-related activities.
As part of our regular close-out procedures at the end of
each project year, practice personnel participated in key
informant interviews to discuss operations from the prior
year. Given the potential impact of COVID-19 responses on
the provision of preventive services, we added discussion
of COVID-19 to our end-of-year interviews in 2020.
The purpose of this paper is to describe key informant
impressions of the impact of the COVID-19 pandemic on
preventive screenings within our participating safety-net
practices, both to inform and contextualize the impact on
screening rates as well as to elucidate any lessons that may
be learned as the pandemic continues.

METHODS

Twelve safety-net primary care practices participated in
the final year of the project, which was determined to be
non-research quality improvement by the institutional
review board of State University of New York Upstate
Medical University. To assess the overall impact of the
project, colorectal, breast, and cervical screening rates
were collected from the 12 practices at two times during
each project year — once at the start of each intervention
year (pre) and once at the end of each intervention year
(post). The time frame for pre and post data varied among
practices and was based on when each practice entered
the project. Data were collected as part of the annual
program evaluation and include numerators representing
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the total number of eligible patients screened within a
given time frame and denominators representing the total
number of patients eligible for screening in that same time
frame. The number of patients screened was collected
by method of screening for each cancer; however, many
practices left these fields blank. Screening rates for each
cancer were aggregated to descriptively evaluate trends
in screening rates from August 2019 to June 2020.
In addition to quantitation of screening rate changes, key
informants from all 12 practices participated in end-ofyear open-ended interviews with a practice facilitator
from the project, including discussion of the perceived
impacts of the COVID-19 pandemic on colorectal, breast,
and cervical cancer screening. The discussions were
held naturalistically, with guide questions indicating the
direction of discussion but not dictating the dialogue.
Qualitative comments pertaining to COVID-19 were
collated by the practice facilitators conducting the
interviews and entered into a shared online form (Google
Docs). Responses were organized by each cancer
screening type or as overarching comments pertaining to
the impact of the pandemic on general cancer screening
priorities and issues across all types.
Once responses from all 12 practices were collated, they
were assessed via brief content analysis, which involved
grouping statements based on similar and reoccurring
keywords and themes. This process was led by one team
member who had not participated in the interviews and was
cross-validated by a second team member who also had
not participated in the interviews. Both of these individuals
have formal training in qualitative data analysis. The
identified themes were then discussed with the broader
team of authors, including interviewer/practice facilitators,
for a third interpretive and analytic step. All responses
were coded without identifying information.
Results include the themes identified in the qualitative
responses and quantitative description of rate changes
for colorectal, breast, and cervical cancer screening.
Other results and outcomes from the project are reported
elsewhere in this issue of Journal of Patient-Centered
Research and Reviews.14,15

RESULTS

An overall increase in mean screening rates was seen from
pre-Y1 to post-Y6 of this project for breast and colorectal
cancers, while cervical cancer screening rates showed an
overall decrease.15 In Y7, colorectal screening saw the
most change (2 percentage point decrease) while cervical
screening remained almost unchanged (0.10 percentage
point decrease). Breast cancer screening increased by about
1 percentage point from the pre-Y7 to post-Y7 period.

COVID-19

All practices responded to the request for information
regarding screenings and COVID-19. Two of the practices
reported no changes in screening across all cancer types
during the pandemic, 1 practice reported slight changes in
screening across all cancer types, and 2 practices reported
major changes in screening across all cancer types during
this time. The remaining practices all reported varying
degrees of change for colorectal, breast, and cervical cancer.
Cervical cancer was reported by the majority of practices
as the least likely screening to experience a change of
any magnitude due to the pandemic, followed closely
by colorectal cancer. Breast cancer was the most likely
screening to experience both slight and major changes due
to COVID-19. A total of 13 themes were codified, with
5 overarching themes and 2 each pertinent to colorectal,
breast, and cervical cancer.
Overarching Themes

Continued Pre-COVID-19 Processes. Several practices
indicated they attempted to continue pre-COVID-19
screening and referral practices to the greatest extent
possible while experiencing reduced patient volumes.
Changes in Data Entry During This Time. Some practices
experienced delays in data entry due to staffing changes;
however, others reported that the slowdown in in-office
activity offered the opportunity to “clean up” existing data.
Telehealth Heavily Relied on During Pandemic, Its Use
Likely to Continue. Many practices switched to telehealth
for the delivery of all services. Those with established
experience and infrastructure to deliver telehealth had
more success than those who had to implement these
processes as a reactive step to a COVID-19 shutdown.
Focus Shifted From Preventive Screening to Caring
for Sick Patients. This was observed across all cancer
types; preventive screening was de-emphasized during
COVID-19 shutdowns.
Many Practices Experienced Decreased Staffing During
This Time. A major impediment was the decrease in
staffing levels during COVID-19 shutdowns.
Colorectal Cancer Screening Themes

Shifted Focus From Preventive Screening. Several
practices indicated that focus had to be shifted away from
all preventive care, such as screening, as demands for
acute care and COVID-19 testing took precedence.
Change in Number of Mailed FIT Kits and Commercial
FIT-DNA Tests. The availability of fecal testing (fecal
immunochemical test [FIT] and commercial FIT-DNA)

COVID-19

allowed practices to shift some of the burden of screening
from in-office, appointment-driven approaches (eg,
colonoscopy) to home-based procedures.
Breast Cancer Screening Themes

Screenings Paused During Summer of 2020. Several
practices paused breast cancer screening, especially since
there was no in-home option (such as those available for
colorectal screening).
Practices Relied on Then-Unavailable Mobile
Mammography Units. Some practices indicated that
mobile mammography units funded by New York State
were the primary means of breast cancer screening
referral; these units stopped operating at the height
of COVID-19 shutdowns, with some units being
operationalized as mobile COVID-19 testing facilities.
Cervical Cancer Screening Themes

Our safety-net primary care practices (family medicine and
general internal medicine) primarily rely on gynecology
referrals and separate providers to manage cervical cancer
screening. During the COVID-19 shutdowns, many
practices opted not to focus on cervical screening. This
change in focus resulted, for some practices, in a stop in
cervical screening and referrals for screening altogether.
Quotes supporting and illustrating identified themes are
included in Tables 1–4.

DISCUSSION

Colorectal cancer screening seemed to be relatively
unchanged by the pandemic; many practices were already
mailing test kits to patients who were due for a screening,
and this continued whether or not patients could be
seen in the office. Practices also had time to follow up
with patients who had had a positive FIT kit before the
pandemic hit, with one practice utilizing the services of
patient navigators to keep in contact with these individuals,
ensuring they could be scheduled for follow-up as soon
as the practice was ready. While most practices increased
the number of FIT kits and commercial FIT-DNA tests
mailed, one practice decreased them, citing concerns
over potential exposure of the samples to COVID-19
through the laboratory they used. While the delay in the
mailing of test kits or the inability to schedule in-person
appointments may have impacted diagnostic ability, none
of the practices reported this as a concern.
For breast cancer, several practice sites involved with the
project utilized the services of mobile mammography vans
or buses within the communities they serve. Historically,
these mobile units increase the number of screenings
that can be done by a practice and address issues of
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Table 1. Overarching Themesa
Theme

Quotes from practices

Continued pre-COVID-19
processes

“The QI team did outreach and follow-up after mailing FIT kits, and GI continued to
schedule colonoscopies.”
“We still handed out FIT kits to patients who came in.”
“We’re slightly backlogged from before the pandemic, but the mammography bus is still
doing two times a month.”
“We see the greatest success with getting patients to complete this screening [breast]
because it is the least invasive and requires very limited interaction with a medical site.”
“We continued to refer out for Pap smears.”

Changes in data entry during
this time

“There was delay in entering screening data, which led to inaccurate rates.”

Telehealth was heavily relied
on during this time, and
practices will likely continue
to use this technology

“The practice plans to continue using telemed after the pandemic so long as it continues to
be covered/reimbursed.”

“Our practice also had some time available to go in and ‘clean up’ patient records and data,
which was valuable.”

“The practice will continue telemed if they are able to and it is an option for patients, but
many are underserved or don’t have the means to use.”
“The ability to use telehealth was very helpful for our practice, allowing for better
conversations with patients.”

Focus shifted from preventive
screening to caring for sick
patients

“Lots of testing for COVID-19. The immediate focus was to get people in if they were sick
or needed testing, before focusing on additional screenings.”

Many practices experienced
decreased staffing during
this time

“Over the summer, our practice had about half the nursing staff still in office and others
working from home if possible.”

“The focus at the practice has been on sick or necessary visits, as little to no cancer
screening was being done during more hectic times in pandemic.”

“At this practice, there were far fewer people to support the work due to the loss of staff for
several reasons. Some were exposed to or contracted COVID-19 and some had their time
reallocated to hospitals to support the response.”
“Three care coordinators were furloughed during the pandemic.”

Themes were developed from practice responses to the question, “Each previous question was asked about screening for
specific cancer types. Is there anything you would add as an overall comment, as additional information, or as a summary?”
a

FIT, fecal immunochemical test; GI, gastroenterology; QI, quality improvement; telemed, telemedicine.

accessibility for patients who are due for screening.18,19
During the pandemic, many of these mobile screening units
were repurposed for COVID-19 testing, which severely
impacted the ability of practices who relied on these units
to conduct breast cancer screening. Once rates of infection
slowed in New York State and practices adjusted to a “new
normal,” they were able to slowly ramp up breast cancer
screenings. Some practices regained access to their mobile
mammography units, but others did not.
According to anecdotal reports from our own participating
practices, cervical cancer screening has historically
been difficult for primary care practices to target and
track because many patients seek this service at outside
obstetrics/gynecology (OB/GYN) facilities. Sharing
information across practice sites requires dedicated
effort, and practices do not always have the bandwidth to
track these screening records. Cervical cancer screening
continued to be a problem for many sites during the onset
350 JPCRR • Volume 8, Issue 4 • Fall 2021

of COVID-19 restrictions, with many OB/GYN clinics
closed for preventive care and fewer staff available to
monitor patient data between sites.
Practices who historically serve high-risk populations,
including homeless, refugee, and elderly patients,
encouraged these individuals to stay home if they were
healthy. Some practices closed entirely for periods of time,
and many practices saw reduced staffing from sickness or
reassignment to help hospitals with their overwhelming
need. A few practices saw the decrease of patient visits
as an opportunity to improve their preventive screenings,
either by cleaning up patient records and data or by
filming screening tutorial videos that can be used for all
patients, including after the pandemic.
Telehealth was extremely useful for practices during this
time. Many stated that they will continue to use telehealth
as long as it remains reimbursable. However, telehealth
COVID-19

Table 2. “Did your approach to screening patients for colorectal cancer change at all as a result of the
COVID-19 pandemic? If it did not – please say so. If it did change – how?”
Theme

Quotes from practices

Shifted focus from preventive
screenings

“We continued to offer FIT kits but focused mainly on sick or immediate appointments.”

Change in the number of FIT
kits and commercial FIT-DNA
tests that were mailed

“We focused solely on mailing FIT kits because patients could not come in for colonoscopies
and tripled the amount of kits mailed during this time, with roughly an 80% return rate.”

“Our focus was on outreach instead of in-office screening.”

“We printed lists of everyone who was due and created … [commercial FIT-DNA] orders
for patients … mailed letters to those who already had kits but hadn't completed them, and
those with old FIT kits received a new … [commercial FIT-DNA] order.”
“We pulled back on mailing FIT kits because results are run by an internal lab and there
were concerns about exposure [to COVID-19] with receiving returned sample.”

FIT, fecal immunochemical test.

Table 3. “Did your approach to screening patients for breast cancer change at all as a result of the COVID-19
pandemic? If it did not – please say so. If it did change – how?”
Theme

Quotes from practices

Screenings were paused
during the summer of 2020

“As of September 2020, our practice has slowly begun rescheduling and making
appointments.”
“Patients were unable to come in for mammograms, so the focus was on mailing
information to those who were due.”

Practices relied on mobile
mammography units that
were unable to be used

“The mammography bus was temporarily halted but began again in June 2020. Fewer
people are getting screened, but still continuing.”
“Mobile mammography is no longer available, as it was turned into a mobile COVID-19
testing site.”

Table 4. “Did your approach to screening patients for cervical cancer change at all as a result of the COVID-19
pandemic? If it did not – please say so. If it did change – how?”
Theme

Quotes from practices

Cervical cancer screening was “Cervical had been a focus but also a struggle to improve. At this point, it is not a key focus
no longer a central focus
for the site.”
“We focus on outreach instead of in-office screening.”
No screening or referrals
occurred

“Our practice started offering Pap smears in-office this year but had to delay this during
initial COVID-19 impacts.”
“Little to no screening occurred during this time, as it wasn't a priority.”

presented issues when patients did not have the means
to access the technology necessary for appointments.
Practices that had experience using telehealth tended to
be more comfortable, and more successful, with its use
during COVID-19 operational restrictions.
One practice noted that the greatest barriers to screenings
are now patient financial concerns. In a time when income
is potentially much more limited due to unemployment,
COVID-19

patients may be unable to pay for screening or for
potential follow-up if a screening is positive.
Limitations

One limitation of this study is the inability to compare the
months of the pandemic in Y7 (March–June) with those
same months from previous project years. Our data were
collected at two time points each year based on prescribed
dates. Without screening rate data for each month, we
aah.org/jpcrr

351

are unable to directly compare screening rates solely for
March–June 2020. Our analysis focused on qualitative
reports from practices that reported the changes they saw
on the ground rather than quantitative screening data.

CONCLUSIONS

Despite dramatic changes in operations when COVID-19
restrictions took effect in the spring of 2020, primary care
practices participating in our project were able to shift focus
from traditional cancer screening support (usually involving
direct patient communication during an office visit) to
processes that support screening outside of in-person office
visits. These include shifting colorectal cancer screening
to home-based fecal testing methods, the use of telehealth
to assess and communicate with patients, and the use of
staff time for database and registry cleaning to identify
more patients due for screening when the capacity to do
so returned. Also, most practices were on improvement
trajectories with their screening rates, and these trajectories
flattened during the pandemic response. However, a
dramatic decline in screening was not observed, rather,
practices deployed creative problem-solving to maintain
screening rates as COVID-19 restrictions took hold.
Patient-Friendly Recap
• The COVID-19 pandemic disrupted cancer screening
workflows of safety-net primary care practices, many
of which experienced loss of dedicated staff or relied
on OB/GYN offices that halted preventive screenings.
• Telehealth, though available in primary care prior to
COVID-19, became further integrated into practices
and a vital aspect to the continuation of screenings.
However, it was less impactful for patients with
financial or technological disadvantages.
• Practices adapted to maintain prepandemic
screening rates by increasing the accuracy of
electronic medical records, reaching out to patients
regarding their screening, referring patients for
off-site mammography, and mailing lab tests for
colorectal cancer.
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